Billionaires Holding FATE

BILLIONAIRE ALLOCATION SHARES OWNED (M) % CO AVG. COST RETURN

FUNDAMENTALS

  • N/A
    PE

  • 0.0
    Yield

  • 20.6M
    Shares Outstanding

  • 94.19M
    Market Cap

News & Insights

ABOUT

FATE

Fate Therapeutics, Inc. provides biotechnology services. The Company researches and develops therapies to repair and regenerate body tissues with the help of stem cells. Fate Therapeutics conducts business in the United States.

Buffett's key to investing: Four stocks that show a durable competitive advantage

NEWS

Icahn Enterprises launches tender offer for Federal-Mogul shares at 5.6% discount

READ MORE